Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats

Mahmoud Teaima,1 Rehab Abdelmonem,2 Yomna A Adel,3 Mohamed A El-Nabarawi,1 Tayseer M El-Nawawy3 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Mi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Teaima M, Abdelmonem R, Adel YA, El-Nabarawi MA, El-Nawawy TM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	telmisartan tel entrapment efficiency ee transethosomes iontophoresis. Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/1045fae53fa44876b4783bf01c778e26
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1045fae53fa44876b4783bf01c778e26
record_format	dspace
spelling	oai:doaj.org-article:1045fae53fa44876b4783bf01c778e262021-11-09T18:40:35ZTransdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats1177-8881https://doaj.org/article/1045fae53fa44876b4783bf01c778e262021-11-01T00:00:00Zhttps://www.dovepress.com/transdermal-delivery-of-telmisartan-formulation-in-vitro-ex-vivo-ionto-peer-reviewed-fulltext-article-DDDThttps://doaj.org/toc/1177-8881Mahmoud Teaima,1 Rehab Abdelmonem,2 Yomna A Adel,3 Mohamed A El-Nabarawi,1 Tayseer M El-Nawawy3 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, Giza, 12566, Egypt; 3Department of Pharmaceutics, Egyptian Drug Authority, Cairo, EgyptCorrespondence: Mahmoud TeaimaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, EgyptEmail mahmoud.teaima@pharma.cu.edu.egPurpose: The purpose of this study was to prepare telmisartan transethosomes, incorporate them into a gel, evaluate them for in vitro drug release and in vivo permeation using iontophoresis to enhance their transdermal delivery.Materials and Methods: TE formulae were prepared using various surfactants (SAAs), different ethanol concentrations, and different phospholipid-to-SAA ratios with different cholesterol ratios, characterized according to their entrapment efficiency percentage (EE%), zeta potential (ZP), particle size (PS), and polydispersity index (PDI). The optimum three formulae were incorporated into a gel, evaluated physically, in vitro dissolution, and ex vivo drug permeation using rat skin and Iontophoresis was performed on the best formula.Results: The optimum three formulae (F29, F31, F32) had an EE% of 97± 0.26%, 89± 0.25% and 88± 0.17%, PS of 244± 5.88 nm, 337± 4.6 nm and 382.2± 3.06 nm, PDI of 0.57± 1.9, 0.5± 1.4 and 0.63± 2.2 and ZP of − 31.6± 1.59 mV, − 28.3± 3.79 mV and − 31± 5.65, respectively. Selecting F29 for in vivo study by iontophoretic enhancement, Cmax was increased by 1.85 folds compared to the commercial oral tablet and by 1.5 folds compared to transdermal gel. Tmax decreased by half using iontophoresis compared to commercial tablets and transdermal gel.Conclusion: The transethosomal formulation of telmisartan enhanced its transdermal absorption and increased its bioavailability as well. Iontophoresis was used to increase maximum plasma concentration and reduce Tmax by half.Keywords: telmisartan, TEL, entrapment efficiency, EE, transethosomes, iontophoresisTeaima MAbdelmonem RAdel YAEl-Nabarawi MAEl-Nawawy TMDove Medical Pressarticletelmisartantelentrapment efficiencyeetransethosomesiontophoresis.Therapeutics. PharmacologyRM1-950ENDrug Design, Development and Therapy, Vol Volume 15, Pp 4603-4614 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	telmisartan tel entrapment efficiency ee transethosomes iontophoresis. Therapeutics. Pharmacology RM1-950
spellingShingle	telmisartan tel entrapment efficiency ee transethosomes iontophoresis. Therapeutics. Pharmacology RM1-950 Teaima M Abdelmonem R Adel YA El-Nabarawi MA El-Nawawy TM Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
description	Mahmoud Teaima,1 Rehab Abdelmonem,2 Yomna A Adel,3 Mohamed A El-Nabarawi,1 Tayseer M El-Nawawy3 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, Giza, 12566, Egypt; 3Department of Pharmaceutics, Egyptian Drug Authority, Cairo, EgyptCorrespondence: Mahmoud TeaimaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, EgyptEmail mahmoud.teaima@pharma.cu.edu.egPurpose: The purpose of this study was to prepare telmisartan transethosomes, incorporate them into a gel, evaluate them for in vitro drug release and in vivo permeation using iontophoresis to enhance their transdermal delivery.Materials and Methods: TE formulae were prepared using various surfactants (SAAs), different ethanol concentrations, and different phospholipid-to-SAA ratios with different cholesterol ratios, characterized according to their entrapment efficiency percentage (EE%), zeta potential (ZP), particle size (PS), and polydispersity index (PDI). The optimum three formulae were incorporated into a gel, evaluated physically, in vitro dissolution, and ex vivo drug permeation using rat skin and Iontophoresis was performed on the best formula.Results: The optimum three formulae (F29, F31, F32) had an EE% of 97± 0.26%, 89± 0.25% and 88± 0.17%, PS of 244± 5.88 nm, 337± 4.6 nm and 382.2± 3.06 nm, PDI of 0.57± 1.9, 0.5± 1.4 and 0.63± 2.2 and ZP of − 31.6± 1.59 mV, − 28.3± 3.79 mV and − 31± 5.65, respectively. Selecting F29 for in vivo study by iontophoretic enhancement, Cmax was increased by 1.85 folds compared to the commercial oral tablet and by 1.5 folds compared to transdermal gel. Tmax decreased by half using iontophoresis compared to commercial tablets and transdermal gel.Conclusion: The transethosomal formulation of telmisartan enhanced its transdermal absorption and increased its bioavailability as well. Iontophoresis was used to increase maximum plasma concentration and reduce Tmax by half.Keywords: telmisartan, TEL, entrapment efficiency, EE, transethosomes, iontophoresis
format	article
author	Teaima M Abdelmonem R Adel YA El-Nabarawi MA El-Nawawy TM
author_facet	Teaima M Abdelmonem R Adel YA El-Nabarawi MA El-Nawawy TM
author_sort	Teaima M
title	Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
title_short	Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
title_full	Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
title_fullStr	Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
title_full_unstemmed	Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
title_sort	transdermal delivery of telmisartan: formulation, in vitro, ex vivo, iontophoretic permeation enhancement and comparative pharmacokinetic study in rats
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/1045fae53fa44876b4783bf01c778e26
work_keys_str_mv	AT teaimam transdermaldeliveryoftelmisartanformulationinvitroexvivoiontophoreticpermeationenhancementandcomparativepharmacokineticstudyinrats AT abdelmonemr transdermaldeliveryoftelmisartanformulationinvitroexvivoiontophoreticpermeationenhancementandcomparativepharmacokineticstudyinrats AT adelya transdermaldeliveryoftelmisartanformulationinvitroexvivoiontophoreticpermeationenhancementandcomparativepharmacokineticstudyinrats AT elnabarawima transdermaldeliveryoftelmisartanformulationinvitroexvivoiontophoreticpermeationenhancementandcomparativepharmacokineticstudyinrats AT elnawawytm transdermaldeliveryoftelmisartanformulationinvitroexvivoiontophoreticpermeationenhancementandcomparativepharmacokineticstudyinrats
_version_	1718440811223318528

Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats

Ejemplares similares